Drug Use Evaluation of Tenofovir/Lamivudine/Dolutegravir (TLD) Fixed-Dose Combination for Initiation and Transition ...
Introduction The backbone for HIV treatment has been the combination of at least two nucleosides (nucleotide) reverse transcriptase inhibitors (NRTIs) and a third drug from any of the following medication groups: Non-nucleoside reverse transcriptase …